|
|
||||||||||||||
1. Identity of the issuer or the underlying issuer |
Assura Group Limited |
||||||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): |
|||||||||||||||
An acquisition or disposal of voting rights |
|
||||||||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
√ |
||||||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
||||||||||||||
An event changing the breakdown of voting rights |
|
||||||||||||||
Other (please specify): |
|
|
|||||||||||||
3. Full name of person(s) subject to the |
Moore Europe Capital Management, LLP |
||||||||||||||
4. Full name of shareholder(s) |
RH Moore, LP |
||||||||||||||
5. Date of the transaction and date on |
19 January 2011 |
||||||||||||||
6. Date on which issuer notified: |
21 January 2011 |
||||||||||||||
7. Threshold(s) that is/are crossed or |
5% |
||||||||||||||
8. Notified details: |
|||||||||||||||
A: Voting rights attached to shares viii, ix |
|||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
|||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
|||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
|||||||||||
ORD 10P SHARES |
14,616,936 |
14,616,936 |
14,616,936 |
14,616,936 |
N/A |
4.60% |
N/A |
||||||||
GB0033732602 |
|||||||||||||||
|
|||||||||||||||
B: Qualifying Financial Instruments |
|||||||||||||||
Resulting situation after the triggering transaction |
|||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
|||||||||||
(i) Firm Placing Ordinary Shares
(ii) Open Offer Ordinary Shares
|
N/A
N/A
|
Immediately
Please see details of the Recommended Offer by Assura Group Limited for the entire issued and to be issued share capital of AH Medical Properties plc. |
2,222,223
Maximum amount of Open offer shares is 2,222,222 of which 2,222,222 shares are subject to claw-back.
|
0.70%
0.70%
Total = 1.40%
|
|||||||||||
|
|||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
|||||||||||||||
Resulting situation after the triggering transaction |
|||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
||||||||||
|
|
|
|
|
Nominal |
Delta |
|||||||||
|
|
||||||||||||||
|
|||||||||||||||
Total (A+B+C) |
|||||||||||||||
Number of voting rights |
Percentage of voting rights |
||||||||||||||
19,061,381 |
6% |
||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
Proxy Voting: |
|||||||||||||||
10. Name of the proxy holder: |
N/A |
||||||||||||||
11. Number of voting rights proxy holder will cease |
N/A |
||||||||||||||
12. Date on which proxy holder will cease to hold |
N/A |
||||||||||||||
|
|||||||||||||||
|
|
||||||||||||||
14. Contact name: |
Philip Ost |
||||||||||||||
15. Contact telephone number: |
+44 (0)20 7470 7478
|
||||||||||||||